CASI Pharmaceuticals
CASI
#8753
Rank
A$0.12 B
Marketcap
$8.26
Share price
-7.55%
Change (1 day)
107.51%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$40.72 M

According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$40.38 M. In 2023 the company made an earning of -A$39.56 M an increase over its 2022 earnings that were of -A$56.15 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$40.72 M2.94%
2023 -A$39.56 M-29.55%
2022 -A$56.15 M4.43%
2021 -A$53.76 M-24.56%
2020 -A$71.27 M4.74%
2019 -A$68.04 M65.13%
2018 -A$41.21 M155.07%
2017 -A$16.16 M13.93%
2016 -A$14.18 M31.18%
2015 -A$10.81 M-72.5%
2014 -A$39.31 M356.62%
2013 -A$8.61 M-60.55%
2012 -A$21.82 M218.41%
2011 -A$6.86 M0.74%
2010 -A$6.81 M-32.54%
2009 -A$10.09 M-66.98%
2008 -A$30.54 M-14.22%
2007 -A$35.6 M7.04%
2006 -A$33.26 M27.95%
2005 -A$25.99 M4.51%
2004 -A$24.87 M-15.84%
2003 -A$29.55 M-55.29%
2002 -A$66.1 M-34.05%
2001 -A$0.11 B31.73%
2000 -A$76.08 M31.56%
1999 -A$57.83 M145.56%
1998 -A$23.55 M76.4%
1997 -A$13.35 M36.92%
1996 -A$9.75 M